http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009076226-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ff1daed47656ce2b8d1e690275e1516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ee0da6543d4d16f0634e75baf2d0d58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0208
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
filingDate 2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57468bdf913bf5cfd70c96a23072dc94
publicationDate 2009-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009076226-A1
titleOfInvention Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use
abstract The present invention is directed to mutants of lysine decarboxylase, nucleic acids encoding the mutants, and vaccines comprising the mutants for inhibiting and reducing the development of periodontal diseases, including gingivitis and chronic periodontitis. The vaccine composition comprises a recombinant lysine decarboxylase mutant which is based on a native version of the enzyme from E. corrodens and induces production of antibodies that inhibit the activity of the lysine decarboxylase enzyme in the oral cavity. The recombinant lysine decarboxylase mutant, in one version, comprises a mutation at residue 365 or at other locations within the active site, and in a preferred embodiment is produced from E. coli in large amounts and to form inclusion bodies. The purified inclusion bodies can then be used in the vaccine composition to induce in vivo production of antibodies that inhibit the activity of native E. corrodens lysine decarboxylase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108795912-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108795912-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108795916-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108795916-B
priorityDate 2007-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827698-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6187296-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006270043-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19777023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128448066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128492838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129476615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73950587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766

Total number of triples: 47.